Perrigo (PRGO) Misses Q4 EPS by 1c; Offers FY20 EPS Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Pre-Open Stock Movers 2/25: (MNK) (LL) (MRNA) Higher (TUP) (PANW) (SHAK) Lower (more...)
February 25, 2020 9:21 AM ESTToday's Pre-Open Stock Movers
Mallinckrodt Plc (NYSE: MNK) 38.2% HIGHER; its specialty generic unit will file for bankruptcy protection as it agreed to settle opioid-related cases globally by paying $1.6 billion over eight years.
Perrigo (PRGO) Gains 10% on FDA Approval for Generic ProAir HFA
February 25, 2020 7:13 AM ESTPerrigo (NYSE: PRGO) gains 9.6% in pre-open trade after the FDA approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm.
... More